Long-term SARS-CoV-2 RNA shedding and its temporal association to IgG seropositivity

[1]  Gilbert GREUB,et al.  Comparison of SARS-CoV-2 RT-PCR on a high-throughput molecular diagnostic platform and the cobas SARS-CoV-2 test for the diagnostic of COVID-19 on various clinical samples , 2020, Pathogens and disease.

[2]  Eric Song,et al.  Analytical sensitivity and efficiency comparisons of SARS-CoV-2 RT–qPCR primer–probe sets , 2020, Nature Microbiology.

[3]  C. Pawlowski,et al.  Longitudinal laboratory testing tied to PCR diagnostics in COVID-19 patients reveals temporal evolution of distinctive coagulopathy signatures , 2020, medRxiv.

[4]  Tomislav Bedeković,et al.  Evaluation of Serological Tests for Detection of Antibodies against Lumpy Skin Disease Virus , 2020, Journal of Clinical Microbiology.

[5]  L. Kucirka,et al.  Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction–Based SARS-CoV-2 Tests by Time Since Exposure , 2020, Annals of Internal Medicine.

[6]  J. Thachil,et al.  Coagulation abnormalities and thrombosis in patients with COVID-19 , 2020, The Lancet Haematology.

[7]  A. Phelan,et al.  COVID-19 immunity passports and vaccination certificates: scientific, equitable, and legal challenges , 2020, The Lancet.

[8]  D. Montefiori,et al.  Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2 , 2020, bioRxiv.

[9]  E. Theel,et al.  The Role of Antibody Testing for SARS-CoV-2: Is There One? , 2020, Journal of Clinical Microbiology.

[10]  D. Raoult,et al.  Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards , 2020, European Journal of Clinical Microbiology & Infectious Diseases.

[11]  B. La Scola,et al.  Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards , 2020, European Journal of Clinical Microbiology & Infectious Diseases.

[12]  Eun Ji Kim,et al.  Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. , 2020, JAMA.

[13]  Zhenshun Cheng,et al.  The presence of SARS‐CoV‐2 RNA in the feces of COVID‐19 patients , 2020, Journal of medical virology.

[14]  P. Vollmar,et al.  Virological assessment of hospitalized patients with COVID-2019 , 2020, Nature.

[15]  M. C. Muenker,et al.  Analytical sensitivity and efficiency comparisons of SARS-CoV-2 RT–qPCR primer–probe sets , 2020, Nature Microbiology.

[16]  Robert C. Walchak,et al.  Evaluation of Saline, Phosphate-Buffered Saline, and Minimum Essential Medium as Potential Alternatives to Viral Transport Media for SARS-CoV-2 Testing , 2020, Journal of Clinical Microbiology.

[17]  O. Tsang,et al.  Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study , 2020, The Lancet Infectious Diseases.

[18]  H. Shan,et al.  Prolonged presence of SARS-CoV-2 viral RNA in faecal samples , 2020, The Lancet Gastroenterology & Hepatology.

[19]  Eric H. Y. Lau,et al.  Temporal dynamics in viral shedding and transmissibility of COVID-19 , 2020, Nature Medicine.

[20]  Quanyi Wang,et al.  Highly accurate and sensitive diagnostic detection of SARS-CoV-2 by digital PCR , 2020, Talanta.

[21]  Qi Zhao,et al.  Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2 , 2020, International journal of biological sciences.

[22]  K. Kim,et al.  What Is COVID-19? , 2020, Frontiers for Young Minds.

[23]  J. Xiang,et al.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.

[24]  En-Ming Kang,et al.  Positive result of Sars-Cov-2 in sputum from a cured patient with COVID-19 , 2020, Travel Medicine and Infectious Disease.

[25]  Fang Liu,et al.  ddPCR: a more accurate tool for SARS-CoV-2 detection in low viral load specimens , 2020, Emerging microbes & infections.

[26]  D. Garcin,et al.  IFN-λ prevents influenza virus spread from the upper airways to the lungs and limits virus transmission , 2018, eLife.

[27]  Jonathan J Deeks,et al.  Cellular immune correlates of protection against symptomatic pandemic influenza , 2013, Nature Medicine.

[28]  Pei-Jer Chen,et al.  Emerging hepatitis B virus infection in vaccinated populations: a rising concern? , 2012, Emerging Microbes & Infections.

[29]  G. Bren,et al.  Patients with Discordant Responses to Antiretroviral Therapy Have Impaired Killing of HIV-Infected T Cells , 2010, PLoS pathogens.

[30]  Eriko,et al.  Analytical sensitivity and efficiency comparisons of SARS-COV-2 qRT-PCR assays , 2020 .